What is NSG BioLabs?
NSG BioLabs operates as Singapore's premier biosafety level 2 (BSL-2) co-working laboratory and office space, dedicated to empowering life sciences companies. Spanning 70,000 sq ft, the facility offers scalable infrastructure, including BSL-2 certified labs and office environments equipped with advanced technology and over 400 pieces of equipment. NSG Bio fosters a collaborative ecosystem for both startups and established multinational corporations, providing critical support and networking opportunities to accelerate innovation and scientific discovery within the biotechnology landscape.
How much funding has NSG BioLabs raised?
NSG BioLabs has raised a total of $14.5M across 1 funding round:
Other Financing Round
$14.5M
Other Financing Round (2024): $14.5M with participation from Celadon Partners
Key Investors in NSG BioLabs
Celadon Partners
Celadon Partners is an Asian private equity firm specializing in venture capital investments across the Asia-Pacific region, with a particular focus on China. The firm identifies and invests in transformative innovations, aiming to generate long-term returns through intrinsic value investing and by acting as a business builder.
What's next for NSG BioLabs?
The recent major strategic investment signals a period of accelerated growth and expansion for NSG BioLabs. This capital infusion is expected to enhance its existing infrastructure, potentially broaden its service offerings, and further solidify its position as a catalyst for groundbreaking discoveries in Singapore's vibrant biotech ecosystem. The company is poised to continue its trajectory of nurturing scientific excellence and supporting the development of next-generation life science ventures.
See full NSG BioLabs company page
